Lupin Somerset is recalling approximately 2.2 million bottles of Equate ClearLAX (polyethylene glycol 3350) powder for solution, an over-the-counter osmotic laxative. The recall was issued because the products were labeled with unfiled National Drug Code (NDC) numbers, meaning the identifier on the package does not match official regulatory records. These products were sold nationwide, specifically at Walmart, in 119 g and 238 g bottle sizes with various expiration dates ranging from 2018 to 2021. Consumers should check their containers for the affected lot numbers and contact a healthcare professional regarding their use.
The product labeling contains incorrect regulatory identifiers (NDC numbers), which can lead to confusion in tracking and identifying the medication. While the FDA classifies this as a low-risk labeling issue, it is a violation of labeling requirements; no injuries or adverse health effects have been reported.
Refund available for unused product.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.